Newer formulations are even more effective at preventing illnesses that commonly afflict seniors — perhaps even dementia.

The fifth Symposium on Infectious Disease in the Immunocompromised Host convened in Seattle last month. Experts and rising ...

Frailty strongly predicts worse RSV outcomes in older adults, highlighting the need for targeted care as aging populations ...

A new panel of U.S. vaccine advisers appointed by Health Secretary Robert F. Kennedy Jr. will vote on flu shots that contain ...

Catching the flu or COVID can trigger a heart attack or stroke in vulnerable people. Here’s what we can all do to lower our ...

Dr. Fiona Havers is influential among researchers who study immunizations. The wholesale dismissal of the agency’s scientific ...

A newly approved shot could soon help protect babies from respiratory syncytial virus, the top cause of hospitalization in US infants.

A Seattle infectious disease doctor, whose work was pivotal early in the COVID pandemic, shares more on her experience with ...

Respiratory Syncytial Virus is a growing health concern for Indian infants. Efforts for maternal RSV vaccine faces challenges ...

Cleveland health officials are warning residents after a 250% spike in COVID-19 viral levels was found in city wastewater.

Cleveland Department of Public Health officials are warning of a “strong likelihood of increased community spread in the ...

The FDA has approved Enflonsia (clesrovimab-cfor) for the prevention of RSV lower respiratory tract disease in neonates and ...